Nicola A Hanania (Baylor College of Medicine, TX, US) is a valued member of our Editorial Board for US Respiratory & Pulmonary Diseases. Here he discusses with us the background and findings of his presentation entitled: What Symptomatic Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) Find Important in Their Maintenance Inhaler Therapy: A Focus Group Study (abstract available here).
Questions1. Tell us a little about the Focus Group Study poster you are presenting tomorrow (0:11)
View Part 1 here.
View Part 2 here.
Speaker disclosure: Nicola A Hanania has received honoraria for serving on advisory boards or as a consultant for Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, and Sanofi/Regeneron. His institution has received research grant support on his behalf from Boehringer Ingelheim, AstraZeneca, Roche, and GlaxoSmithKline.
Filmed at the American Thoracic Society (ATS) International Conference 2018, San Diego, CA, US, May 2018.